These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1298 related articles for article (PubMed ID: 8043388)

  • 1. Effect of ultraviolet-inducible cytokines on melanoma growth in vivo: stimulation of melanoma growth by interleukin-1 and -6.
    Mckenzie RC; Park ES; Brown WR; Shivji GS; Sauder DN
    Photodermatol Photoimmunol Photomed; 1994 Apr; 10(2):74-9. PubMed ID: 8043388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
    McKenzie RC; Oran A; Dinarello CA; Sauder DN
    Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
    Belizario JE; Dinarello CA
    Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
    Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
    Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-alpha and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.
    Eisenthal A; Cameron RB; Rosenberg SA
    J Immunol; 1990 Jun; 144(11):4463-71. PubMed ID: 2111349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosis.
    Epperly MW; Travis EL; Sikora C; Greenberger JS
    Biol Blood Marrow Transplant; 1999; 5(4):204-14. PubMed ID: 10465100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of interleukin (IL)-2 and IL-15 in the tumour progression of a melanoma cell line MELP, derived from an IL-2 progressor patient.
    Doucet C; Meazza R; Pottin-Clemenceau C; Scudeletti M; Brouty-Boye D; Ferrini S; Alileche A; Taoufik Y; Jasmin C; Azzarone B; Indiveri F
    Melanoma Res; 1997 Aug; 7 Suppl 2():S7-17. PubMed ID: 9578412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts.
    Diaz A; Chepenik KP; Korn JH; Reginato AM; Jimenez SA
    Exp Cell Res; 1998 May; 241(1):222-9. PubMed ID: 9633531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
    Martínez-Esparza M; Solano F; García-Borrón JC
    Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sinusoidal endothelium release of hydrogen peroxide enhances very late antigen-4-mediated melanoma cell adherence and tumor cytotoxicity during interleukin-1 promotion of hepatic melanoma metastasis in mice.
    Anasagasti MJ; Alvarez A; Martin JJ; Mendoza L; Vidal-Vanaclocha F
    Hepatology; 1997 Apr; 25(4):840-6. PubMed ID: 9096586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.
    Wirjatijasa F; Dehghani F; Blaheta RA; Korf HW; Hailer NP
    J Neurosci Res; 2002 Jun; 68(5):579-87. PubMed ID: 12111847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
    Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
    Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of interleukin 8 expression in human malignant melanoma cells.
    Singh RK; Varney ML
    Cancer Res; 1998 Apr; 58(7):1532-7. PubMed ID: 9537260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
    Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
    Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The expression of ICAM-1 on macrophages stimulated with Mycobacterium avium complex and its control by some regulatory cytokines].
    Maw WW; Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Oct; 71(10):561-7. PubMed ID: 8936990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin-8 expression in human melanoma cells by the organ environment.
    Gutman M; Singh RK; Xie K; Bucana CD; Fidler IJ
    Cancer Res; 1995 Jun; 55(11):2470-5. PubMed ID: 7758001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple cytokines inhibit interleukin-6-dependent murine hybridoma/plasmacytoma proliferation.
    Schwabe M; Cox GW; Bosco MC; Prohaska R; Kung HF
    Cell Immunol; 1996 Feb; 168(1):117-21. PubMed ID: 8599834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model.
    Ledda MF; Adris S; Bravo AI; Bover L; Carbone C; Paleolog E; Mordoh J; Chernajovsky Y; Podhajcer OL
    Cell Mol Biol (Noisy-le-grand); 1996 Jul; 42(5):769-78. PubMed ID: 8832108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo interferon regulatory factor 3 tumor suppressor activity in B16 melanoma tumors.
    Duguay D; Mercier F; Stagg J; Martineau D; Bramson J; Servant M; Lin R; Galipeau J; Hiscott J
    Cancer Res; 2002 Sep; 62(18):5148-52. PubMed ID: 12234977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.